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OBJECTIVES In order to limit the variability of coronary flow velocity reserve (CFVR), we analyzed which
factors independently affect CFVR and established a new parameter integrating these factors.
BACKGROUND Coronary flow velocity reserve (CFVR) is a frequently used parameter for evaluating the
physiological significance of epicardial stenosis and microvascular function. Since CFVR
measurements are done in substantially different hemodynamic and clinical situations,
interpretation of CFVR requires correction for major influencing factors.
METHODS In 141 patients with angina-like symptoms and angiographically unobstructed coronary
arteries, intracoronary Doppler measurements were performed in at least two coronary vessels.
Coronary flow velocity reserve was calculated as the ratio of hyperemic average peak velocity
(hAPV), after intracoronary bolus of adenosine, to baseline average peak velocity (bAPV).
RESULTS Analysis of covariance revealed that only bAPV (p , 0.0001) and age (p , 0.0001) were
independent factors influencing CFVR. Based on a regression model for estimation of
predicted CFVR values, individual CFVR values (CFVRind) obtained at different bAPV and
age were transformed in corrected CFVR values (CFVRcorr) by relating them to a mean
bAPV of 15 cm/s and a mean age of 55 years. The transformation from CFVRind into
CFVRcorr for the left anterior descending artery can be done by using the following equation:
CFVRcorr 5 2.85pCFVRindp10
0.48plog(bAPV) 1 0.0025page 2 1.16. When applying this new
parameter to conditions assumed to cause microvascular dysfunction, analysis showed that
only patients with diabetes showed a significant decrease of traditional CFVR and CFVRcorr,
whereas a history of hypertension and current smoking habit had no influence on CFVRcorr.
CONCLUSIONS The concept of CFVRcorr standardizes CFVR for bAPV and age as the major physiological
determinants. Especially in patients with microvascular dysfunction, this approach may help
to discriminate between conditions directly affecting vasodilator reserve and conditions
primarily affecting bAPV. (J Am Coll Cardiol 2000;35:1713–20) © 2000 by the American
College of Cardiology
Due to limitations of assessment of coronary perfusion by
coronary angiography, physiological approaches have been
suggested for assessing the severity of coronary stenosis.
Based on the fundamental works by Gould et al. (1) who
developed the concept of coronary flow reserve in general
terms, Wilson and colleagues (2) introduced the concept of
coronary flow velocity reserve (CFVR) as a surrogate for
evaluating the physiological significance of luminal narrow-
ing. Coronary flow velocity reserve was defined as the ratio
of maximal to resting flow velocity, which represents the
coronary vasodilator capacity. Although many studies have
evaluated CFVR in clinical practice (3–5), the interpretation
of CFVR values remains controversial. Normal values for
CFVR were reported to range from 2.3 to 4.8 (6–9). Due to
such variability of CFVR, it has been difficult to establish
true normal values and to interpret CFVR in individual
patients. It is known that factors affecting resting myocar-
dial blood flow velocity, like heart rate (10) and blood
pressure (11), can influence CFVR. Additionally, a de-
creased CFVR has been reported with increasing age (12)
and in disorders causing an increased cardiac work load like
aortic stenosis (13). Although it has been proposed to relate
myocardial blood flow reserve to blood flow at rest and age
(12) or to standardize for heart rate by atrial pacing (8), to
our knowledge, no concept has been developed to integrate
these parameters into interpretation of CFVR until now.
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The goal of this study was: 1) to evaluate which factors
influence CFVR in patients with angiographically unob-
structed coronary arteries and to which extent these factors
contribute to the variability of CFVR values, 2) to establish
a model to correct CFVR for these factors, and 3) to
evaluate this model in patients who meet the Doppler
criteria of microvascular dysfunction as recently proposed by
comparing coronary flow reserve and CFVR (14).
METHODS
Patients. The study was performed in 141 patients under-
going diagnostic coronary angiography for suspected coro-
nary artery disease, who showed angiographically unob-
structed coronary arteries (i.e., coronary arteries with an
angiographically smooth silhouette). Patients with valvular
heart disease, hypertrophic obstructive cardiomyopathy, di-
lative cardiomyopathy, endocarditis or myocarditis were
excluded from the study. Doppler data were only included
for further evaluation if there were no signs of myocardial
bridging (15). Measurements were performed in at least two
major coronary arteries, the left anterior descending artery
(LAD), left circumflex artery (LCX) and right coronary
artery (RCA). Patient characteristics are summarized in
Table 1. All participating patients gave written, informed
consent. The study was approved by the local ethical
committee.
Measurement of intracoronary hemodynamic parame-
ters. Intracoronary Doppler was performed with a 0.014 in.
Doppler wire (FloWire, Cardiometrics, Corp., California),
as previously validated and described by Doucette et al. (16).
Electrocardiogram (ECG), coronary ostial pressure, instan-
taneous spectral peak velocity and time average spectral peak
flow velocity were recorded on-line. Heart rate, obtained
from the ECG, and blood pressure, obtained from the
guiding catheter, were recorded simultaneously during Dopp-
ler flow analysis. Angiography and Doppler measurements
were documented on compact disc and videotape, respec-
tively, for off-line analysis. The position of the Doppler wire
was documented by the Echomap-System (Siemens, Erlan-
gen, Germany) in a picture—in picture mode and saved in
the DICOM3 format (17).
Coronary flow velocity measurements were performed
after routine coronary angiography. A 7F or 8F guiding
catheter without side holes was inserted in the left or right
coronary artery without damping of the aortic pressure
signal. All patients received 5,000 I.E. heparin and 0.2 mg
intracoronary nitroglycerine before angiography and an
additional 3,000 I.E. heparin at the beginning of the
intracoronary Doppler examination. The Doppler wire was
advanced into the target segment of the vessel, and, after a
stable and high quality baseline signal without significant
artefacts was obtained, baseline parameters were recorded.
Then an intracoronary bolus of 18 mg adenosine in the left
or 12 mg adenosine in the right coronary artery was injected,
and peak hyperemic conditions were recorded. Coronary
flow velocity reserve was calculated as the ratio of hyperemic
average peak velocity (hAPV) and baseline average peak
velocity (bAPV) (18). All measurements were performed
twice. In case of disagreement, the mean value was calcu-
lated from two consecutive measurements. Doppler mea-
surements were performed in the LAD in segment 7 or 8, in
the LCX in segment 13 and in the RCA in segment 3. All
141angiographiccatheterizationprocedures includingDopp-
ler measurements were performed without complications.
Statistics. As a first step, factors potentially influencing
CFVR were separately explored for each vessel by univariate
regression analysis. The following factors were examined:
systolic blood pressure, diastolic blood pressure, heart rate,
age, bAPV and body mass index (BMI). The potential
influence of gender on CFVR was analyzed by unpaired t
test. To normalize data CFVR values and bAPV values were
Abbreviations and Acronyms
a 5 log10 transformed for statistical analysis
bAPV 5 baseline average peak velocity
BMI 5 body mass index
CFVR 5 coronary flow velocity reserve
CFVRcorr 5 corrected coronary flow velocity reserve—
CFVR value corrected for bAPV and age
CFVRind 5 individual coronary flow velocity reserve of
a certain patient
CFVRpred 5 predicted coronary flow velocity reserve—
CFVR value predicted by the covariance
model for a certain bAPV and age
ECG 5 electrocardiogram
hAPV 5 hyperemic average peak velocity
LAD 5 left anterior descending artery
LCX 5 left circumflex artery
RCA 5 right coronary artery
Table 1. Patient Characteristics
Patients examined: (total No. of patients) 141
Women 65 (46.1%)
Men 76 (63.9%)
Age* (yrs) 54.9 6 11.8
Body mass index (kg*m22)*: 26.4 6 4.1
Hemodynamic parameters†:
Heart rate* (beats/min): 79 6 15.4
Systolic blood pressure* (mm Hg): 147 6 27.5
Diastolic blood pressure* (mm Hg): 75 6 15.4
Exercise tests
Stress ECG
Number of patients 109
Adequate exercise end points 55
Positive 30 (55%)
Negative 25 (45%)
*Mean 6 standard deviation; †during intracoronary Doppler examination.
ECG 5 electrocardiogram.
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log10-transformed before analysis (
a)(CFVRa, bAPVa). In a
second step, we performed a multiple covariance analysis to
evaluate these factors simultaneously. Analysis of factors
potentially affecting bAPV was also done by multiple
covariance analysis. Factors included here were age, BMI,
systolic blood pressure, diastolic blood pressure, heart,
gender and coronary vessel.
Finally, estimation of predicted values and 95% prognos-
tic intervals for CFVR was done by regression analysis.
Those factors were included that were found to be statisti-
cally significant in the second step after appropriate adjust-
ment for multiple testing according to Bonferroni.
To avoid bias by repetitive measurements in the same
patient, the evaluation of CFVR and corrected coronary
flow velocity reserve—CFVR value corrected for bAPV and
age—(CFVRcorr) with regard to microvascular function was
only done with data derived from LAD Doppler measure-
ments (135 patients). As recently proposed, microvascular
dysfunction in women was proposed when CFVR was less
than 2.24 (14). For evaluation of this cut-off value, only
results from female patients were included (n 5 65).
The estimation of predicted values and prognostic inter-
vals were performed for each coronary vessel separately. All
p values are two-sided. P values of less than 0.05 were
considered to indicate statistical significance. Data analysis
was performed using the SAS statistical package (version
6.12).
RESULTS
Descriptive statistics. A total of 141 patients participated
in the study. In 72 of 141 patients (51%), intravascular
Doppler measurements were performed in all three major
epicardial vessels and in 69 of 141 patients (49%) in two
vessels. For details of descriptive statistics of intracoronary
Doppler measurements see Table 2.
Univariate regression analysis. Significant correlations be-
tween CFVRa and systolic blood pressure, heart rate, age
and bAPVa were observed in all major coronary vessels. The
r values in Figure 1 indicate that only between bAPVa and
CFVRa a close correlation existed. A significant correlation
was found between CFVRa and hAPV (r 5 0.28; p 5
0.0019) in the LCX, which could not be demonstrated in
the LAD (r 5 0.05; p 5 0.53) and the RCA (r 5 0.10; p 5
0.28). In the RCA, CFVRa was marginally but significantly
related to diastolic blood pressure (r 5 0.21; p 5 0.033),
whereas no correlation existed between these parameters in
either the LAD or the LCX. Women had a significantly
lower CFVR than men in all coronary vessels. Figure 1
presents the results of univariate regression analysis for the
LAD.
Multiple covariance analysis. Based on the results of
univariate regression, a multiple analysis of covariance was
performed to evaluate factors potentially influencing
CFVRa simultaneously. In this model bAPVa and age were
significantly related to CFVRa. Systolic and diastolic blood
pressure, heart rate, gender, BMI and the coronary vessel
showed no statistically significant influence on CFVRa after
adjustment for multiple testing (Table 3).
Analysis of covariance was performed for bAPV in order
to examine interactions between the variables tested. By this
analysis, statistically significant associations between bAPVa
and systolic blood pressure, heart rate, BMI and gender
were detected, whereas age, diastolic blood pressure and the
coronary vessel showed no effect.
Regression model for predicting CFVR on the basis of
bAPV and age. As only bAPV and age were found to be
relevant predictors of CFVR, we developed a regression
model by which predicted CFVR values (CFVRpred) could
be estimated for a given bAPV and age. Since intracoronary
Doppler measurements were performed in at least two
coronary vessels in all patients, the equation was developed
for each vessel separately. Based on the results in Table 4,
predicted CFVR values can be calculated by the following
equations:
LAD:
CFVRpred 5 101.1620.48plog(bAPV)20.0025page~r 5 0.71, p , 0.0001!.
LCX:
CFVRpred 5 101.1420.45plog(bAPV)20.0031page~r 5 0.63, p , 0.0001!.
RCA:
CFVRpred 5 101.1520.50plog(bAPV)20.0021page~r 5 0.67, p , 0.0001!.
Table 5 summarizes predicted CFVR values and 95%
prognostic intervals for the mean age of 55 years and mean
bAPV of 15 cm/s. Results were corresponding in all three
coronary vessels, and no relevant differences existed.
Method for standardization of CFVR values for bAPV
and age. After adjusting for multiple testing according to
Bonferroni, CFVR was related only to bAPV and age. We
developed a method for correcting CFVR values for these
two parameters. To provide comparability of individual
CFVR values (CFVRind) obtained at different bAPV and











bAPV (cm/s)a 15.6 6 6.4 15.6 6 5.8 12.9 6 5.3**‡
hAPV (cm/s) 43.6 6 13.0 42.6 6 13.5 38.9 6 10.7*‡
CFVRa 3.0 6 0.8 2.8 6 0.8 3.2 6 0.9
†p , 0.05 as compared with LAD; ‡p , 0.01 as compared with LAD; *p , 0.05 as
compared with LCX; **p , 0.01 as compared with LCX.
a 5 log10 transformed for statistical analysis; bAPV 5 baseline average peak
velocity; CFVR 5 coronary flow velocity reserve; hAPV 5 hyperemic average peak
velocity; LAD 5 left anterior descending artery; LCX 5 left circumflex artery;
RCA 5 right coronary artery.
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ages, we standardized CFVR values on a bAPV of 15 cm/s
and an age of 55 years. These values were used because they
represent the mean values of these parameters in our study
population. Corrected coronary flow velocity reserve values




Figure 1. Univariate regression analysis between systolic pressure, diastolic pressure, heart rate, age, baseline average peak velocity (bAPV),
hyperemic average peak velocity (hAPV), body mass index (BMI) and coronary flow velocity reserve (CFVR). Values are plotted against
log10-transformed CFVR values. Results are shown for the left anterior descending artery (LAD).
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By standardizing CFVR values for both bAPV and age, the
variability of CFVR values could be significantly reduced in
all three vessels (Fig. 2).
Application of corrected CFVR to factors assumed to
cause microvascular dysfunction. Univariate regression
analysis showed that there was a significant correlation
between CFVR and bAPV, systolic blood pressure, heart
rate and age. The new parameter CFVRcorr was indepen-
dent of these factors.
Twenty of 65 women patients (31%) presented with a
CFVR of less than 2.24 in the LAD, the cut-off value
recently proposed for microvascular dysfunction in women
(14). These women with suspected microvascular disease
showed a significantly increased bAPV and systolic blood
pressure as compared with patients with CFVR $2.24
(Table 6).
Patients were categorized according to risk factors for
microvascular dysfunction. Patients with a history of hyper-
tension showed a significantly increased bAPV and signif-
icantly reduced CFVR, whereas the CFVRcorr showed no
difference. Patients with diabetes mellitus had a significantly
reduced CFVR and CFVRcorr. No difference with regard to
the bAPV was observed between patients with diabetes and
without diabetes. Smokers had a significantly increased
bAPV and a significantly reduced CFVR. No difference was
observed for CFVRcorr. Cholesterol levels neither affected
traditional CFVR nor CFVRcorr (Table 7).
DISCUSSION
The primary finding of this study is that baseline peak
velocity and age are significant determinants of CFVR in
patients with angiographically unobstructed coronary arter-
ies. In a univariate regression model, heart rate, blood
pressure, gender, age and bAPV correlate with CFVR.
Analysis of covariance revealed that bAPV and age are the
only two independent factors influencing CFVR. The
results suggest that effects of gender, blood pressure and
heart rate are mediated by bAPV. Additionally, our analysis
showed that age, although significantly related to CFVR,
contributes only a minor part to overall correlation. To
improve the quality of interpreting individual CFVR values
in the catheterization laboratory, we developed an equation
for correcting CFVR values for the variables bAPV and age.
Table 3. Analysis of Covariance of CFVRa
Variable Beta (SE beta)b p Value
Age 20.0020 (0.0005) 0.0001*
Body mass index 20.0003 (0.0012) 0.8155
Systolic blood pressure 20.0005 (0.0003) 0.0502
Diastolic blood pressure 0.0014 (0.0005) 0.0034
Heart rate 20.0009 (0.0004) 0.0199
Gender (male vs. female) 0.0301 (0.0117) 0.0106
bAPVa 20.3835 (0.0371) 0.0001*
Vessel
LAD vs. RCX 20.0106 (0.0247)
LAD vs. RCA 0.0024 (0.0264) 0.6650
*After adjustment for multiple testing according to Bonferroni p , 0.003 was
assumed as statistically significant. alog10 transformed for statistical analysis; bSE b,
standard error of b coefficient.
bAPV 5 baseline average peak velocity; CFVR 5 coronary flow velocity reserve;
LAD 5 left anterior descending artery; RCA 5 right coronary artery; RCX 5 right
circumflex artery.
Table 4. Multiple Regression Analysis of CFVRa Used for Prediction
Artery Variable r Intercept Beta (SE beta)b p Value
LAD 0.71 1.1591
Age 20.0024 (0.0006) 0.0002
bAPVa 20.4841 (0.0439) 0.0001
LCX 0.63 1.1393
Age 20.0031 (0.0008) 0.0001
bAPVa 20.4516 (0.0588) 0.0001
RCA 0.67 1.1461
Age 20.0021 (0.0008) 0.0001
bAPVa 20.5006 (0.0565) 0.0001
bSE beta 5 standard error of beta coefficient; bAPVa 5 log 10 transformed baseline average peak velocity; LAD 5 left anterior
descending artery; LCX 5 left circumflex artery; r 5 coefficient of correlation; RCA 5 right coronary artery.
Table 5. Predicted Values of CFVR
Artery
Predicted Value of CFVR at





CFVR 5 coronary flow velocity reserve; LAD 5 left anterior descending artery;
LCX 5 left circumflex artery; RCA 5 right coronary artery.
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Factors affecting CFVR. In humans under experimental
settings, coronary flow reserve decreases progressively as
heart rate increases (8,10). The reduction in coronary flow
reserve is almost entirely caused by an increase in coronary
flow velocity at rest, whereas hyperemic flow is unchanged.
Furthermore, patients with aortic stenosis (13) and arterial
hypertension (11), disorders characterized by an increased
cardiac work load and, thereby, an increased myocardial
resting blood flow, have been shown to have a reduced
CFVR. These observations suggest that an increased base-
line coronary flow velocity may contribute to the reduced
CFVR in these patients. This hypothesis is endorsed by the
close correlation between bAPV and CFVR in the current
study. A potential explanation for this interaction might be
that even small differences in cardiac work load lead to an
increased basal flow velocity in coronary arteries and,
thereby, exhaust parts of the coronary reserve to fulfill
increased demands. Since bAPV was significantly related to
BMI, systolic blood pressure and gender in this study, the
results suggest that changes of bAPV are the summed effect
of these factors. The new parameters, CFVRcorr, showed no
relation to these factors and offer the advantage of being
independent from these hemodynamic parameters.
CFVR in microvascular disease. Apart from evaluating
the physiological significance of epicardial stenoses, intra-
coronary Doppler has become an important tool in patients
with suspected microvascular disease. Recent studies report
an impaired coronary flow reserve in patients with diabetes
mellitus, hypertension and smoking (11,19–22). These
findings are attributed to abnormalities in coronary vaso-
motion. It has been proposed that a coronary flow reserve of
less than 2.5 (23) and a CFVR of less than 2.24 (14) in the
absence of significant epicardial stenosis is a sign of micro-
vascular dysfunction. Categorizing women in this study
according to the cut-off value for CFVR of 2.24 revealed
that women with suspected microvascular dysfunction have
a significantly increased bAPV, and systolic blood pressure.
As these factors may, in part, contribute to the reduction of
CFVR, the use of traditional CFVR as an indicator of
microvascular dysfunction may not sufficiently discriminate
between factors affecting vasodilator reserve and baseline
flow velocity.
In our patients a reduced CFVR was observed for arterial
hypertension, diabetes mellitus and smoking, whereas only
patients with diabetes also had a decreased CFVRcorr.
However, hypertensive patients and smokers had a signifi-
cantly increased bAPV. As CFVRcorr corrects CFVR for
bAPV and age, our data suggest that the reduced CFVR in
hypertensive patients and smokers is, in part, caused by the
increased bAPV and not predominantly by abnormalities in
CFVR. On the other hand, patients with diabetes seem to
have a dysfunction of endothelium-independent vasomo-
tion, which cannot be attributed to changes in basal flow
velocity. Correcting CFVR for baseline flow velocity and
age may help to discriminate between conditions directly
affecting coronary vasodilation and conditions increasing
baseline flow velocity. This concept is supported by the
observation that histologically confirmed microvessel dis-
ease is often accompanied by slow flow phenomenon re-
flecting decreased resting flow velocity (24). In particular,
patients with decreased bAPV showed high traditional
CFVR values in this study.
Standardization of CFVR. Under experimental settings
McGinn et al. (8) could demonstrate that CFVR was
Figure 2. Comparison of standard deviation as a measure of
variability of coronary flow velocity reserve (CFVR) and corrected
coronary flow velocity reserve (CFVRcorr). The figure indicates
that the standard deviation of the new parameter ‘CFVRcorr’ is
significantly lower than the standard deviation of traditional
CFVR. LAD 5 left anterior descending; LCX 5 left circumflex
artery; RCA 5 right coronary artery.
Table 6. Comparison of Hemodynamic Parameters in Women With Suspected Microvascular
Dysfunction (CFVR , 2.24) and Suspected Normal Microvascular Function (CFVR $ 2.24)
(data for LAD/n 5 65)
Parameter CFVR < 2.24 (n 5 20) CFVR > 2.24 (n 5 45) p Value
bAPV 23.7 6 5.8 16.4 6 6.1 , 0.0001
Systolic blood pressure 171 6 35.4 147 6 27.5 0.0027
Heart rate 88 6 15.1 81 6 17.3 0.11
Age 57 6 15.7 56 6 10.5 0.67
bAPV 5 baseline average peak velocity; CFVR 5 coronary flow velocity reserve; LAD 5 left anterior descending artery.
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significantly affected by heart rate and pulmonary capillary
wedge pressure. The observed changes were mediated by
alterations in resting coronary flow velocity, whereas hyper-
emic flow velocity remained unchanged. To obtain a proper
interpretation of CFVR measurements, they proposed to
standardize CFVR by measuring at a paced heart rate of 100
beats/min. Although McGinn’s approach and the concept
of CFVRcorr reflects the same intention to eliminate hemo-
dynamic factors affecting CFVR, maintaining a certain
heart rate by pacing requires major effort in the catheter-
ization laboratory and does not reflect the physiological
stimulation of the heart. Thus, a direct correction of CFVR
for bAPV and age may be more advantageous.
CFVR in assessing the hemodynamic significance of
coronary stenoses. Angiography yields only a limited an-
atomical assessment of coronary vessels, which allows no
reliable prediction as to whether a stenosis causes exercise-
induced ischemia (25,26). Coronary flow velocity reserve
measurements have become an important issue in establish-
ing indications of coronary interventions and evaluating
their results (27,28), in particular as exercise tests docu-
menting ischemia are often not performed before angio-
plasty (29). The Functional Angiometric Correlation with
Thallium Scans Study Group recently reported an 88%
agreement between 201Tl imaging and intracoronary Dopp-
ler measurements using a cut-off value of 1.7 for CFVR
(30). In order to improve reliability of CFVR in evaluating
the significance of a coronary stenosis, the concept of
relative flow reserve has been reintroduced into clinical
application (31). The objective of this approach was to
eliminate factors influencing CFVR like blood pressure,
heart rate and microvascular dysfunction, which affect all
myocardial perfusion territories in a similar fashion. This
leads to a marked improvement of specificity and sensitivity.
Since correction is done intraindividually by comparing
target-vessel CFVR values with values obtained in a refer-
ence vessel, relative flow reserve might be superior to the
concept of CFVRcorr in the presence of an epicardial
stenosis. A shortcoming of this concept is that it requires
measurements in at least two coronary arteries, of which one
has to be definitely unobstructed. Corrected coronary flow
velocity reserve may increase quality of interpretation in
patients who are not eligible for the concept of relative flow
reserve and in patients without obstructed epicardial arter-
ies.
Study limitations. This investigation was performed in
patients with angiographically unobstructed coronary arter-
ies. It has been demonstrated by intracoronary ultrasound
that plaque formation can be found in up to 50% of patients
with normal appearing coronary arteries (32). Although we
think that these early signs of atherosclerosis do not affect
the observed relation between resting blood flow, age and
CFVR, further studies with simultaneous intravascular ul-
trasound and Doppler measurements will have to clarify this
point.
A limitation of this study is that the investigated patients
cannot be taken as truly normal. All presented with angina
suspicious for obstructed coronary artery disease. Since
patients with valvular heart disease or myocarditis did not
participate in the study, microvascular disease must be
assumed in a significant part of these patients. However, the
aim of this study was to disclose factors affecting CFVR in
a large population with unobstructed coronary arteries as
found in daily practice in the catheterization laboratory.
With respect to coronary interventions, the validity of the
concept has to be examined in patients with coronary
stenoses where a physiological assessment is mandatory for
decision-making. Before proposing this concept for clinical
practice, a clear-cut threshold must be established for
determination of the functional relevance of coronary ste-
nosis.
Clinical implications. The concept of CFVRcorr standard-
izes CFVR for bAPV and age as the main determinants.
This approach significantly reduces the high variability of
CFVR. The new equations offer a practical method for a
Table 7. Risk Factors for Microvascular Dysfunction (Data for LAD/n 5 135)
bAPV hAPV CFVR CFVRcorr
No history of hypertension (n 5 63) 14.5 6 5.2 42.1 6 10.4 3.13 6 0.9 2.87 6 0.5
History of hypertension (n 5 72) 17.0 6 7.3 45.3 6 15.2 2.87 6 0.9 2.89 6 0.6
p Value (no hypertension vs. hypertension) 0.017 0.15 0.048 0.77
No diabetes mellitus (n 5 123) 15.4 6 6.3 43.6 6 13.8 3.06 6 0.8 2.91 6 0.6
Diabetes mellitus (n 5 12) 18.3 6 6.5 40.5 6 10.5 2.49 6 0.7 2.55 6 0.5
p Value (no DM vs. DM) 0.17 0.42 0.007 0.04
No smoking (n 5 65) 14.6 6 6.9 42.54 6 12.6 3.16 6 0.8 2.91 6 0.6
Smoking (n 5 70) 16.7 6 5.8 43.9 6 13.7 2.86 6 0.8 2.85 6 0.6
p Value (no smoking vs. smoking) 0.05 0.55 0.03 0.52
Normal cholesterol (#200 mg/dl) (n 5 34) 14.5 6 4.66 42.4 6 10.3 3.07 6 0.7 2.96 6 0.5
Hypercholesterolemia (.200 mg/dl) (n 5 101) 15.5 6 6.53 43.0 6 13.9 3.01 6 0.8 2.84 6 0.6
p Value (normal vs. hypercholesterolemia) 0.4 0.81 0.64 0.25
bAPV 5 baseline average peak velocity; CFVR 5 coronary flow velocity reserve; CFVRcorr 5 corrected coronary flow velocity reserve; DM 5 diabetes mellitus; hAPV 5
hyperemic average peak velocity; LAD 5 left anterior descending artery.
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physiological assessment of CFVR measurements in the
catheterization laboratory in individual patients. As some
disorders suspected to cause microvascular dysfunction also
affect baseline coronary flow velocity, CFVRcorr should be
integrated in the evaluation of microvascular function. This
concept may give additional information in the assessment
of small vessel disease and may help to discriminate between
changes of resting flow velocity and vasodilator reserve.
Reprint requests and correspondence: Dr. Heinrich Wieneke,
Department of Cardiology, University Hospital Essen, D-45122
Essen, Germany. E-mail: heinrich.wieneke@uni-essen.de.
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